HIN 0.00% $2.37 heartware international, inc

hin 1 $bill +, page-7

  1. 228 Posts.
    Fair call but with respect to the board, funding around the prior bid was not easy to get and development the HVAD is extremely expensive. They were nervous given that Ventacor had just running out of money. Using Thoratec's distribution network and expertise, HTWR and THOR would have been unstopped.
 
watchlist Created with Sketch. Add HIN (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.